Govt grants pharma industry 12-month extension for implementing revised Schedule M

The government has extended the deadline for pharma companies to implement updated quality standards by 12 months. This extension helps smaller manufacturers upgrade facilities and meet revised Schedule M requirements. The industry initially sought a two-year extension to address challenges. Firms must now comply with improved manufacturing practices by December 31, 2025.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/tLxlnXP
via IFTTT

Read More

Study estimates about a quarter of Indian population can access stroke facility in an hour

A study finds that only a quarter of India's population can access a stroke rehabilitation centre within an hour. The research highlights the lack of facilities, with less than one ischaemic stroke centre per million people. Improvements in infrastructure are urgently needed to enhance treatment outcomes.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/wPdXQHZ
via IFTTT

Read More

5,000 drug manufacturing units may miss Schedule M deadline, industry seeks extension

Nearly half of India's 10,000 drug manufacturing units might not meet the 2025 deadline for upgrading to revised Schedule M standards, risking closure. Currently, only 2,000 comply with good manufacturing practices. The industry seeks a two-year extension for improvements, but the government hasn't announced one yet. Audits and inspections may begin soon.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/oLR38V0
via IFTTT

Read More

India's first Robotic-assisted Paediatric Gait Trainer for physical rehabilitation launched

Genrobotics launched India's first robotic-assisted Paediatric Gait Trainer, G-Gaiter Paediatric. It aims to improve physical rehabilitation for children with mobility issues. The device uses advanced VR technology and interactive games for therapy. Health Minister Veena George announced its installation at SAT Hospital in Thiruvananthapuram, enhancing healthcare with technology.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/X0RHONz
via IFTTT

Read More

“Nothing to be alarmed”: Health Ministry eases fears as China battles surge in respiratory virus

China is seeing a surge in infections caused by human metapneumovirus (HMPV), mostly in children under 14. Despite the uptick, the Indian health ministry states there is no cause for alarm, with no substantial increase in respiratory outbreaks within the country and prepared healthcare systems.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ocJjpu
via IFTTT

Read More

DJ Group of Institutions attains net debt-free status

DJ Group of Institutions, despite the challenges following the founder's death and regulatory changes, has achieved financial stability under Rhitik Jassar's leadership, turning from a ₹215 crore debt to net debt-free status. Their financial discipline, operational excellence, and strategic financial management have garnered recognition and continued support from key banking partners.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/42TfP5W
via IFTTT

Read More

Big public health upgrade in works; govt hospitals could soon get more firepower

The National Essential Diagnostics List will work as a guide for health facilities in India. It suggests basic tests for village-level centres and more advanced tests for Ayushman Arogya Mandirs and primary health centres. These guidelines aim to improve timely diagnosis and treatment, especially in rural areas.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/9T8lRzA
via IFTTT

Read More